`
`A0 120 (Rev. 08/10)
`
`TO:
`
`Mail Stop 8
`Director of the U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`REPORT ON THE
`FILING OR DETERMINATION OF AN
`ACTION REGARDING A PATENT OR
`TRADEMARK
`
`In Compliance with 35 U.S.C. § 290 and/or 15 U.S.C. § 1116 you are hereby advised that a court action has been
`
`for the District of Delaware
`
`filed in the U.S. District Court
`
`on the following
`
`M Trademarks or
`
`D Patents.
`
`( D the patent action involves 35 U.S.C. § 292.):
`
`DOCKET N0.
`
`PLAINTIFF
`
`DATE FILED
`8/25/2015
`
`U.5. DISTRICT COURT
`for the District of Delaware
`
`DEFENDANT
`
`CEPHALON, INC.
`
`PANACEA BIOTEC, LTD.,
`
`
`
`
`DATE INCLUDED
`
`In the above%ntit1ed case, the following patent(s)/ trademark(s) have been included:
`INCLUDED BY
`
`PATENT OR
`TRADEMARK N0
`
`D Amendment
`DATE OF PATENT
`OR TRADEMARK
`
`D Answer
`
`B Cross Bill
`
`D Other Pleading
`
`HOLDER OF PATENT OR TRADEMARK
`
`In the aboveientitled case, the following decision has been rendered 0r judgement issued:
`DECIS ION/JUDGEMENT
`
`Consent judgment attached
`
`CLERK
`
`John A. Cerino
`
`(BY) DEPUTY CLERK
`
`/s/ Mark Buckson
`
`DATE
`
`3/8/2016
`
`Copy l—Upon initiation of action, mail this copy to Director Copy 3—Up0n termination of action, mail this copy to Director
`Copy 2—Up0n filing document adding patent(s), mail this copy to Director Copy 4—Case file copy
`
`
`
`Case 1:15-cv-OO735-GMS Document 18 Filed 03/08/16 Page 2 of 4 PagelD #: 439
`
`Case 1:15-cv-O'O404-GMS Document 30 Filed 03/01/16 Page 1 of 3 PageID #: 431
`
`IN THE UNITED STATES DISTRICT COURT
`
`FOR THE DISTRICT OF DELAWARE
`
`CA. No. 15-404-GMS (consolidated)
`.
`
`_
`CA. No. 15—735-GMS
`
`) )
`
`)
`
`))
`
`)
`)
`
`) )
`
`) )
`
`)
`)
`
`) )
`
`)
`
`iNRE BENDAMUSTINE CONSOLIDATED
`CASES 11
`.
`
`CEPHALON, rNC.,
`
`Plaintiff,
`
`v.
`
`'
`. PANACEA BIOTEC LTD.,
`
`Defendant.
`
`CONSENT JUDGMENT BETWEEN
`
`CEPHALON, INC. AND PANACEA BIOTEC LTD.
`
`Cephalon, Inc. (“film”) and Panacea Biotec, Ltd. (“Defendant”) have agreed to terms
`
`and conditions representing a negotiated settlement of this action and have set forth those terms
`
`and conditions in a Settlement and License Agreement, dated February. 29, 2016 (the “Settlement
`
`and License Agreement”). Now the parties, having consented and stipulated to the entry of this
`
`Consent Judgment, as follows:
`
`IT IS HEREBY ORDERED, ADJUDGED AND DECREED that:
`
`1.
`
`This Court has jurisdiction over the parties and the subject matter of this action;
`
`2.»
`Plaintiff has asserted that its United States Patent Nos. 8,445,524; 8,669,279;
`8,791,270; 8,883,836 and 8,895,756 (“the patents-in-suli ”) are enforceable and valid and that the
`
`patents-in-suit would be infringed by the manufacture, use, sale, offer for sale, or importation of
`
`Defendant’s Products, as defined in the Settlement and License Agreement and described in
`
`Defendant’s AbbreViated New Drug Application No. 207543 (“Defendant’s ANDA”);
`
`
`
`Case 1:15-cv-00735-GMS Document 18 Filed 03/08/16 Page 3 of 4 PagelD #: 440
`
`Case 1:15-cv-OO404-GMS Document 30 Filed 03/01/16 Page 2 of 3 PageID #: 432
`
`3.
`
`In view of the Settlement and License Agreement, the parties have agreed to
`
`forego any further litigation involving their respective assertions of infringement,
`
`invalidity
`
`and/or unenforceability;
`
`4.
`
`Judgment 'is hereby entered in favor of Plaintiff, as Defendant has admitted solely
`
`with respect to Defendant’s ANDA and Defendant’s Products that
`
`the patents—in-suit are
`
`enforceable and valid and that one or more of the patents-in-suit would be infringed by the
`
`manufacture, use, sale, offer for sale, or importation of Defendant’s Products;
`
`5.
`
`1 Pursuant 'to 35 U.S.C. §27l(e)(4)(A), the effective date of any approval-of the
`
`products that are the subject of Defendant’s ANDA shall be not earlier than the expiration of the
`
`patents—in-suit, except to the extent expressly permitted by Plaintiff under the Settlement and
`
`License Agreement;
`
`6.
`
`Pursuant to 35 U.S.C. § 27l(e)(4)(B), and 35 U.S.C. § 283, Defendant, including
`
`its respective officers, agents, servants, employees, attorneys, and other persons who are in active
`
`concert or participation with the individuals who receive actual notice of this Consent Judgment
`
`are enjoined from making, using, offering to sell, or selling within the UnitedlStates, or
`
`importing into the United States, Defendant’s Products until the expiration of the patents-in—suit,
`
`except
`
`to the extent expressly permitted by Plaintiff under the Settlement and License
`
`Agreement;
`
`'
`
`'7.
`
`Each Party shall bear its own costs, attorneys’ fees, and expenses incurred in
`
`connection .with this action; and
`
`8.
`
`This Court retains jurisdiction to enforce or supervise performance under this
`
`Consent Judgment and the Settlement and License Agreement. '
`
`
`
`Case 1:15-cv-00735—GMS Document 18 Filed 03/08/16 Page 4 of 4 PagelD #: 441
`Case 1:15-cv-00404-GMS Document 30 Filed 03/01/16 Page 3 of 3 PagelD #: 433
`
`/s/ Karen E. Keller
`
`/s/ Sean M Brennecke
`
`Sean M. Brennecke (No. 4686)
`KLEHR HARRISON HARVEY BRANZBURG LLP
`919 North Market Street, Suite 1000
`Wilmington, DE 19801
`(302) 552—55 1 8
`sbrennecke@klehr.com
`
`William A. Harvey
`KLEHR HARRISON HARVEY BRANZBURG LLP
`1835 Market Street, Suite 1400
`Philadelphia, PA 19103
`(215) 569-3003
`~
`OF COUNSEL:
`
`_
`
`,
`
`Sri K. Sankaran
`Devan V. Padmanabhan
`
`,
`WINTHROP & WEINSTINE, P.A.
`225 South Sixth Street, Suite 3500
`
`'
`
`Minneapolis, MN 55402
`(612) 604-6400
`
`John W. Shaw (No. 3362)
`Karen E. Keller (No. 4489)
`David M. Fry (No. 5486)
`SHAW KELLER LLP r,
`300 Delaware Ave., Suite 1120
`Wilmington, DE 19801
`(302) 298—0700
`jshaw@shawkeller.com
`kkeller@shawkeller.com
`dfry@shawkeller.com
`Attorneysfor Plaintz'flCepha/on, Inc.
`
`,
`
`‘
`
`OF COUNSEL:
`David M. Hashmall
`
`Calvin E. Wingfield Jr.
`Jonathan A. Auerbach
`
`Joshua A. Whitehill
`GOODWIN PROCTER LLP
`
`The New York Times Building
`620 Eighth Avenue
`New York, NY 10018
`(212) 813-8800
`
`Paul F. Ware
`
`Daryl L. Wiesen
`Emily L. Rapalino
`Nicholas K. Mitrokostas
`GOODWIN PROCTER LLP
`
`Exchange Place
`Boston, MA 02109
`
`(617) 570-1000
`
`Dated: March 1,2016
`
`IT IS SO ORDERED, DECREED,‘AND ADJUDGED‘this
`
`r
`
`2 Hméi
`
`, 2016
`
`
`
`